Molecular Biology News and Research

RSS

Molecular biology is the study of biology at a molecular level. The field overlaps with other areas of biology and chemistry, particularly genetics and biochemistry. Molecular biology chiefly concerns itself with understanding the interactions between the various systems of a cell, including the interactions between DNA, RNA and protein biosynthesis as well as learning how these interactions are regulated.

GSA announces recipients of 2010 awards for distinguished service in the field of genetics

The Genetics Society of America (GSA) is pleased to announce the recipients of its five awards for distinguished service to the field of genetics. These awards represent sustained activity and contributions by members of the genetics community.

29 Jan 2010

Researchers reveal major shifts in structure of scientific research

How has the structure of scientific research changed over the past decade? A team of researchers from Ume- University, Sweden, and the University of Washington, USA, aims to answer this question and others in a study published on January 27th in the online, open-access journal PLoS ONE.

29 Jan 2010

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Life Technologies Corporation today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

From Danaher 28 Jan 2010

Greg Morgan awarded the Derek Price/Rod Webster Prize

Greg Morgan, an Associate Professor of Philosophy at Stevens Institute of Technology, was recently awarded the Derek Price/Rod Webster Prize for best paper of 2009 in History of Science by the History of Science Society.

28 Jan 2010

Researchers challenge prevailing belief about role of protein in abnormal cell proliferation

In a study to be published this week, a research team is challenging a prevailing belief about the behavior of a human protein linked to the formation of cancer, possibly breathing new life into the search for therapies that will inhibit that protein from "turning on" genes involved in abnormal cell proliferation.

27 Jan 2010

Study sheds light on cellular communication systems involved in neurodegenerative, cancer and cardiovascular diseases

Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.

27 Jan 2010

FDA approves Novo Nordisk's Victoza for type 2 diabetes

Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

27 Jan 2010

Texas to invest $4.5 mn in cancer research at UT Health Science Center

Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.

27 Jan 2010

Applied Biosystems signs cross-licensing agreement with Idaho Technology

Applied Biosystems LLC, part of Life Technologies Corporation, and Idaho Technology, Inc. have signed a cross-licensing agreement which covers a broad range of products including hardware, software and reagents.

27 Jan 2010

Loss of key proteins may account for molecular abnormalities associated with myotonic dystrophy

Research on the genetic defect that causes myotonic muscular dystrophy has revealed that the mutation disrupts an array of metabolic pathways in muscle cells through its effects on two key proteins.

24 Jan 2010

Sexual reproduction leads to lesser accumulation of harmful DNA mutations than asexual reproduction

Living organisms have good reason for engaging in sexual, rather than asexual, reproduction according to Maurine Neiman, assistant professor of biology in the UI College of Liberal Arts and Sciences and researcher in the Roy J. Carver Center for Genomics.

22 Jan 2010

Thomas S. Kilduff named a Fellow of the AAAS

SRI International, an independent nonprofit research and development institute, announced today that Thomas S. Kilduff, Ph.D., director of SRI International's Center for Neuroscience, has been named a Fellow of the American Association for the Advancement of Science (AAAS).

22 Jan 2010

TriLink BioTechnologies and Nacalai USA enter into distribution agreement

TriLink BioTechnologies (TriLink), has entered into an agreement with Nacalai USA, Inc., a San Diego based manufacturing and marketing company, for the distribution of TriLink's modified nucleic acid products in Japan, Singapore, South Korea and Taiwan.

21 Jan 2010

Scientists explore new ways to counteract viral infections

For the first time the research world has managed to measure the energy that is used when a virus infects a cell. The aim is to find a way to reduce the amount of energy inside the virus and thereby ultimately find a medicine that can counteract infections.

20 Jan 2010

Scientists discover Ebola's immune evasion strategies

A research team led by Gaya Amarasinghe, an assistant professor of biochemistry, biophysics and molecular biology, had previously solved the structure of a critical part of an Ebola protein known as VP35, which is involved in host immune suppression.

20 Jan 2010

Interdisciplinary nature of biological research triggers changes to JBC's publishing policies

The Journal of Biological Chemistry's editors are unveiling this week a number of changes to the journal's publishing policies. They say the changes are in response to the increasingly interdisciplinary nature of biological research and will help the journal better meet the evolving needs of the scientific community.

19 Jan 2010

EMBL-EBI hosts drug discovery database

ChEMBLdb, a vast online database of information on the properties and activities of drugs and drug-like small molecules and their targets, launches today with information on over half a million compounds. The data lie at the heart of translating information from the human genome into successful new drugs in the clinic.

19 Jan 2010

Scientists determine structure of enzyme essential to the survival of protozoan parasites

After many years of study, a team of researchers is releasing data today that it hopes will lead to new drug therapies that will kill the family of parasites that causes a deadly trio of insect-borne diseases and has afflicted inhabitants of underdeveloped and developing nations for centuries.

18 Jan 2010

Researchers identify six essential oils that can suppress inflammation

For those who do not drink, researchers have found that six essential oils -from thyme, clove, rose, eucalyptus, fennel and bergamot-can suppress the inflammatory COX-2 enzyme, in a manner similar to resveratrol, the chemical linked with the health benefits of red wine. They also identified that the chemical carvacrol was primarily responsible for this suppressive activity.

18 Jan 2010

Mutagenic drugs designed to kill viruses may make them stronger, says research

As the flu season continues in full-swing, most people can appreciate the need for drugs that stop viruses after they take hold in the body. Despite this serious need for new drugs, a team of researchers from the University of Texas at Austin raise serious concerns about an emerging strategy for stopping viral infections.

18 Jan 2010

Molecular Biology News and Research

Further Reading

GSA announces recipients of 2010 awards for distinguished service in the field of genetics

Researchers reveal major shifts in structure of scientific research

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Greg Morgan awarded the Derek Price/Rod Webster Prize

Researchers challenge prevailing belief about role of protein in abnormal cell proliferation

Study sheds light on cellular communication systems involved in neurodegenerative, cancer and cardiovascular diseases

FDA approves Novo Nordisk's Victoza for type 2 diabetes

Texas to invest $4.5 mn in cancer research at UT Health Science Center

Applied Biosystems signs cross-licensing agreement with Idaho Technology

Loss of key proteins may account for molecular abnormalities associated with myotonic dystrophy

Sexual reproduction leads to lesser accumulation of harmful DNA mutations than asexual reproduction

Thomas S. Kilduff named a Fellow of the AAAS

TriLink BioTechnologies and Nacalai USA enter into distribution agreement

Scientists explore new ways to counteract viral infections

Scientists discover Ebola's immune evasion strategies

Interdisciplinary nature of biological research triggers changes to JBC's publishing policies

EMBL-EBI hosts drug discovery database

Scientists determine structure of enzyme essential to the survival of protozoan parasites

Researchers identify six essential oils that can suppress inflammation

Mutagenic drugs designed to kill viruses may make them stronger, says research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News